Showing results (301-310 of 6,987) with videos related to
Sort By:
Pageof 699
Cancer Science|December 19, 2013
IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndromeKunihiko Moriya, Mika K Kaneko, Xing Liu, et al.Cancer Science|December 31, 2013
Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomasKeiko Furukawa, Mariko Kambe, Maiko Miyata, et al.Cancer Science|December 21, 2013
Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1Kana Hashi, Naoko Murata-Kamiya, Christine Varon, et al.Cancer Science|January 3, 2022
Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune functionHui Tian, Gang Wang, Qiping Wang, et al.Cancer Science|January 8, 2022
Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancerTakamasa Koga, Kenichi Suda, Tetsuya MitsudomiCancer Science|March 17, 2021
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancerAtsushi Okabe, Atsushi KanedaCancer Science|March 17, 2021
miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinomaLi Jiang, Yong Zhang, Bo Li, et al.Cancer Science|March 17, 2021
The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell deathDaisuke Kawauchi, Masamichi Takahashi, Kaishi Satomi, et al.Cancer Science|December 10, 2021
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR-139-3p/CCL5 axisPei Cao, Bo Ma, Ding Sun, et al.Cancer Science|March 18, 2021
Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agentsTakao Ukaji, Ai Takemoto, Harumi Shibata, et al.Pageof 699